Abstract Library

Welcome to the open-access search for all ENETS abstracts presented at the Annual ENETS Conferences.

Everyone can browse the library to find basic information on abstracts. To get full access to each entry, you will be asked to log in to your myENETS account.

 

Please note:

Participants of the 2025 ENETS Conference enjoy full access to the 2025 conference digital resources through myENETS: the abstract booklet, e-posters and videos, slide decks of talks, the poster carousel, and more.

Log in to myENETS

ENETS Abstract Search

#3337 Somatostatin analogues in the treatment of enteropancreatic neuroendocrine tumors

Introduction: Enteropancreatic neuroendocrine tumors are rare neoplasms.

Conference: 18th Annual ENETS Concerence (2021)

Presenting Author: Correa R

Authors: Sanchez Dominguez G, Jiménez J, Sanchez J, Correa R, Alegria J,

Keywords: enteropancreatic neuroendocrine tumor,

#3220 OPERA: Observational study of perception of information and quality of life (QoL) in patients with gastroenteropancreatic neuroendocrine tumors (GEP-NETs) starting Lanreotide Autogel (LAN)

Introduction: The perception of information provided to patients with cancer upon diagnosis may influence adherence to treatment and QoL, but data are scarce in GEP-NETs.

Conference: 18th Annual ENETS Concerence (2021)

Presenting Author: Hautefeuille V

Authors: Hautefeuille V, Walter T, Do Cao C, Coriat R, Dominguez S,

Keywords: somatostatin analogues, quality of life, QLQINFO25, QLQC30, gastroenteropancreatic neuroendocrine tumor,

#3132 Plasmatic and urinary 5-hydroxyindolacetic acid measurements in patients with midgut neuroendocrine tumors: A GTE study

Introduction: Although 24-hour urinary 5-hydroxyindolacetic acid (24u5HIAA) is a key biomarker in midgut NET, it may be inaccurate and inconvenient.

Conference: 18th Annual ENETS Concerence (2021)

Presenting Author: de Mestier L

Authors: de Mestier L, Savagner F, Brixi H, Do Cao C, Dominguez S,

Keywords: neuroendocrine tumor, carcinoid syndrome, 5-hydroxyindolacetic acid, biomarker, diagnosis,

#3009 OPERA: Observational Study of Perception of Information and Quality of Life in Patients with Gastroenteropancreatic NeuroEndocrine TumoRs Starting LAnreotide Autogel–Baseline Characteristics

Introduction: Information provided to patients (pts) with neuroendocrine tumors (NETs) about burden and treatment proposed may influence pts’ adherence to treatment, outpatient monitoring and quality of life (QoL), but can also cause anxiety.

Conference: 17th Annual ENETSConcerence (2020)

Presenting Author: Hautefeuille V

Authors: Hautefeuille V, Do Cao C, Coriat R, Dominguez S, Mineur L,

Keywords: Patients’ perception of information, Quality of Life, Lanreotide,

#2004 OPALINE Study: Observational Study in a Real-World Setting of the Systemic Treatment of Progressive Unresectable or Well-Differentiated Metastatic Pancreatic Neuroendocrine Tumors (pNET)

Introduction: OPALINE Study focuses on patients with pNET. 2 targeted therapies (TT) offer new options to treat these patients: mTORi (everolimus) and a multi-targeted inhibitor (sunitinib).

Conference: 15th Annual ENETSConcerence (2018)

Presenting Author:

Authors: Lombard-Bohas C, Lepage C, Vicaut E, Dominguez S, Coriat R,

Keywords: pNET, targeted therapies,